{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:54:12Z","timestamp":1790265252412,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s00246-023-03138-5","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T00:50:23Z","timestamp":1679878223000},"page":"1359-1363","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Acute Effects of Sacubitril\/Valsartan with Initial Initiation in Pediatric Patients in the Cardiac Intensive Care Unit"],"prefix":"10.1007","volume":"45","author":[{"given":"Rohit S.","family":"Loomba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faeeq","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Nelson-McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"3138_CR1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR, Investigators P-H, Committees (2014) Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371:993\u20131004","journal-title":"N Engl J Med"},{"key":"3138_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2022.101412","author":"A Rahhal","year":"2022","unstructured":"Rahhal A, Kasem M, Orabi B, Hamou F, Abuyousef S, Mahfouz A, Alyafei S, Shoukry AE, Ahmed E (2022) Effectiveness of sacubitril\/valsartan in heart failure with reduced ejection fraction using real-world data: an updated systematic review and meta-analysis. Curr Probl Cardiol. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101412","journal-title":"Curr Probl Cardiol"},{"key":"3138_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ahj.2017.07.006","volume":"193","author":"R Shaddy","year":"2017","unstructured":"Shaddy R, Canter C, Halnon N, Kochilas L, Rossano J, Bonnet D, Bush C, Zhao Z, Kantor P, Burch M, Chen F (2017) Design for the sacubitril\/valsartan (LCZ696) compared with enalapril study of pediatric patients with heart failure due to systemic left ventricle systolic dysfunction (PANORAMA-HF study). Am Heart J 193:23\u201334","journal-title":"Am Heart J"},{"key":"3138_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/PCC.0b013e3181b806fc","volume":"11","author":"MG Gaies","year":"2010","unstructured":"Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG, Charpie JR, Hirsch JC (2010) Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 11:234\u2013238","journal-title":"Pediatr Crit Care Med"},{"key":"3138_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.754499","volume":"8","author":"D Pascual-Figal","year":"2021","unstructured":"Pascual-Figal D, Bayes-Genis A, Beltran-Troncoso P, Caravaca-Perez P, Conde-Martel A, Crespo-Leiro MG, Delgado JF, Diez J, Formiga F, Manito N (2021) Sacubitril-valsartan, clinical benefits and related mechanisms of action in heart failure with reduced ejection fraction. A Review Front Cardiovasc Med 8:754499","journal-title":"A Review Front Cardiovasc Med"},{"key":"3138_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMoa1812851","volume":"380","author":"EJ Velazquez","year":"2019","unstructured":"Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E, Investigators P-H (2019) Angiotensin-neprilysin inhibition in acute decompensated heart failure. N Engl J Med 380:539\u2013548","journal-title":"N Engl J Med"},{"key":"3138_CR7","doi-asserted-by":"publisher","first-page":"6665","DOI":"10.1038\/s41598-020-63801-2","volume":"10","author":"MV Polito","year":"2020","unstructured":"Polito MV, Silverio A, Rispoli A, Vitulano G, Auria F, De Angelis E, Loria F, Gigantino A, Bonadies D, Citro R, Carrizzo A, Galasso G, Iaccarino G, Vecchione C, Ciccarelli M (2020) Clinical and echocardiographic benefit of Sacubitril\/Valsartan in a real-world population with HF with reduced ejection fraction. Sci Rep 10:6665","journal-title":"Sci Rep"},{"key":"3138_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.021459","volume":"10","author":"SJ Greene","year":"2021","unstructured":"Greene SJ, Choi S, Lippmann SJ, Mentz RJ, Greiner MA, Hardy NC, Hammill BG, Luo N, Samsky MD, Heidenreich PA, Laskey WK, Yancy CW, Peterson PN, Curtis LH, Hernandez AF, Fonarow GC, O\u2019Brien EC (2021) Clinical effectiveness of sacubitril\/valsartan among patients hospitalized for heart failure with reduced ejection fraction. J Am Heart Assoc 10:e021459","journal-title":"J Am Heart Assoc"},{"key":"3138_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101149","volume":"41","author":"DY Chen","year":"2021","unstructured":"Chen DY, Chen CC, Tseng CN, Chen SW, Chang SH, Huang WK, Wen MS, Hsieh MJ, Hsieh IC (2021) Clinical outcomes of Sacubitril\/Valsartan in patients with acute heart failure: a multi-institution study. EClinicalMedicine 41:101149","journal-title":"EClinicalMedicine"},{"key":"3138_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jchf.2019.08.003","volume":"8","author":"NY Tan","year":"2020","unstructured":"Tan NY, Sangaralingham LR, Sangaralingham SJ, Yao X, Shah ND, Dunlay SM (2020) Comparative effectiveness of sacubitril-valsartan versus ACE\/ARB therapy in heart failure with reduced ejection fraction. JACC Heart Fail 8:43\u201354","journal-title":"JACC Heart Fail"},{"key":"3138_CR11","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s12325-018-0710-4","volume":"35","author":"DD Antol","year":"2018","unstructured":"Antol DD, Casebeer AW, DeClue RW, Stemkowski S, Russo PA (2018) An early view of real-world patient response to sacubitril\/valsartan: a retrospective study of patients with heart failure with reduced ejection fraction. Adv Ther 35:785\u2013795","journal-title":"Adv Ther"},{"key":"3138_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/00015385.2018.1473825","volume":"74","author":"P Martens","year":"2019","unstructured":"Martens P, Lambeets S, Lau CW, Dupont M, Mullens W (2019) Impact of sacubitril\/valsartan on heart failure admissions: insights from real-world patient prescriptions. Acta Cardiol 74:115\u2013122","journal-title":"Acta Cardiol"},{"key":"3138_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1001\/jamacardio.2019.4665","volume":"5","author":"AD DeVore","year":"2020","unstructured":"DeVore AD, Braunwald E, Morrow DA, Duffy CI, Ambrosy AP, Chakraborty H, McCague K, Rocha R, Velazquez EJ, Investigators P-H (2020) Initiation of angiotensin-neprilysin inhibition after acute decompensated heart failure: secondary analysis of the open-label extension of the PIONEER-HF trial. JAMA Cardiol 5:202\u2013207","journal-title":"JAMA Cardiol"},{"key":"3138_CR14","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/ejhf.1498","volume":"21","author":"R Wachter","year":"2019","unstructured":"Wachter R, Senni M, Belohlavek J, Straburzynska-Migaj E, Witte KK, Kobalava Z, Fonseca C, Goncalvesova E, Cavusoglu Y, Fernandez A, Chaaban S, Bohmer E, Pouleur AC, Mueller C, Tribouilloy C, Lonn E, J ALB, Gniot J, Mozheiko M, Lelonek M, Noe A, Schwende H, Bao W, Butylin D, Pascual-Figal D, Investigators T (2019) Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study. Eur J Heart Fail 21:998\u20131007","journal-title":"Eur J Heart Fail"},{"key":"3138_CR15","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12872-021-02145-9","volume":"21","author":"W Rattanavipanon","year":"2021","unstructured":"Rattanavipanon W, Sotananusak T, Yamaae F, Chandrsawang A, Kaewkan P, Nathisuwan S, Yingchoncharoen T (2021) Real-world experience of angiotensin receptor\/neprilysin inhibitor (ARNI) usage in Thailand: a single-center, retrospective analysis. BMC Cardiovasc Disord 21:324","journal-title":"BMC Cardiovasc Disord"},{"key":"3138_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006645","volume":"13","author":"M Fudim","year":"2020","unstructured":"Fudim M, Sayeed S, Xu H, Matsouaka RA, Heidenreich PA, Velazquez EJ, Yancy CW, Fonarow GC, Hernandez AF, DeVore AD (2020) Representativeness of the PIONEER-HF clinical trial population in patients hospitalized with heart failure and reduced ejection fraction. Circ Heart Fail 13:e006645","journal-title":"Circ Heart Fail"},{"key":"3138_CR17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00059-017-4671-1","volume":"44","author":"R De Vecchis","year":"2019","unstructured":"De Vecchis R, Ariano C, Di Biase G, Noutsias M (2019) Sacubitril\/valsartan for heart failure with reduced left ventricular ejection fraction: a retrospective cohort study. Herz 44:425\u2013432","journal-title":"Herz"},{"key":"3138_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/FJC.0000000000000641","volume":"73","author":"L Vicent","year":"2019","unstructured":"Vicent L, Esteban-Fernandez A, Gomez-Bueno M, De-Juan J, Diez-Villanueva P, Iniesta AM, Ayesta A, Gonzalez-Saldivar H, Rojas-Gonzalez A, Bover-Freire R, Iglesias D, Garcia-Aguado M, Perea-Egido JA, Martinez-Selles M (2019) Sacubitril\/valsartan in daily clinical practice: data from a prospective registry. J Cardiovasc Pharmacol 73:118\u2013124","journal-title":"J Cardiovasc Pharmacol"},{"key":"3138_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025621","volume":"100","author":"Z Pang","year":"2021","unstructured":"Pang Z, Pan C, Yao Z, Ren Y, Tian L, Cui J, Liu X, Zhang L, Chen Y (2021) A study of the sequential treatment of acute heart failure with sacubitril\/valsartan by recombinant human brain natriuretic peptide: A randomized controlled trial. Medicine (Baltimore) 100:e25621","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"3138_CR20","doi-asserted-by":"publisher","first-page":"e001294","DOI":"10.1136\/openhrt-2020-001294","volume":"7","author":"EE Nielsen","year":"2020","unstructured":"Nielsen EE, Feinberg JB, Bu FL, Hecht Olsen M, Raymond I, Steensgaard-Hansen F, Jakobsen JC (2020) Beneficial and harmful effects of sacubitril\/valsartan in patients with heart failure: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis. Open Heart 7(2):e001294","journal-title":"Open Heart"},{"key":"3138_CR21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ihj.2022.04.003","volume":"74","author":"TS Bhat","year":"2022","unstructured":"Bhat TS, Hafeez I, Tak SF, Mattoo A, Patigaroo AR, Khan A, Lone AA, Beig JR (2022) Safety and efficacy of ARNI (valsartan\/sacubitril) vs ACEI (enalapril) in acute heart failure - A prospective observational study. Indian Heart J 74:178\u2013181","journal-title":"Indian Heart J"},{"key":"3138_CR22","doi-asserted-by":"publisher","first-page":"42","DOI":"10.21037\/cdt-21-386","volume":"12","author":"Y Dong","year":"2022","unstructured":"Dong Y, Xu Y, Ding C, Yu Z, Yu Z, Xia X, Chen Y, Jiang X (2022) Comparing the efficacy of angiotensin receptor-neprilysin inhibitor and enalapril in acute anterior STEMI patients after primary percutaneous coronary intervention: a prospective randomized trial. Cardiovasc Diagn Ther 12:42\u201354","journal-title":"Cardiovasc Diagn Ther"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00246-023-03138-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-023-03138-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:04:55Z","timestamp":1721127895000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00246-023-03138-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["3138"],"URL":"https:\/\/doi.org\/10.1007\/s00246-023-03138-5","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"11 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}